Evidence map›Paper›PMID 33176697›Full record

ArticleBMC infectious diseases2020

Antiviral mechanism of carvacrol on HSV-2 infectivity through inhibition of RIP3-mediated programmed cell necrosis pathway and ubiquitin-proteasome system in BSC-1 cells.

Li Wang, Dan Wang, Xingan Wu, Rui Xu, Yunlan Li

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Green, Ultrasound-Assisted Extraction for Carvacrol-RichMolecules (Basel, Switzerland) · 2025
    Article
  3. Pharmaceutics · 2025
    Review
  4. Review
  5. Review
  6. Sweet Basil (Plants (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Article
  9. Antiviral Effect of Polyphenolic Substances inEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Li WangThe First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
Dan WangDepartment of Scientific Research, the Second Affiliated Hospital of Xi' an Medical University, Xi'an, China.
Xingan WuDepartment of Pathogenic Microorganism, School of Preclinical Medicine, Air Force Medical University, Xi'an, China.
Rui XuThe First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
Yunlan LiSchool of Pharmaceutical Science, Shanxi Medical University, No. 36, Xin Jian South Road, Taiyuan, 030001, China. liyunlanrr@163.com.
Xi'an Medical University · CNAir Force Medical University · CNShanxi Medical University · CN

Funding

Education Department Special Scientific Research Projects of Shaanxi Province, China 20JC031Key Research & Development Projects of Shaanxi Province, China 2017SF-336 and 2019SF-163the National Natural Science Foundation of China 81973411the National Science and Technology Major Project of China 2018ZX09101003001-017
6 · The paper itself

Abstract

backgroundCarvacrol, as the major components of aromatic plants used for treating human skin diseases including origanum, Satureja, thymus, and coridothymus species, presented a kind of antiviral activity. To explore the mechanisms of carvacrol against herpes simplex virus (HSV) in vitro.

methodThe BSC-1 cells model of HSV infection was established, and from the two aspects of viral replication level and cell death pathway, the antiviral effects of carvacrol on HSV infected cells were also evaluated by plaque assay under the three modes including prevention, treatment, and direct inactivation.

resultsIn the three ways, the half-maximal effective concentration (EC

conclusionCarvacrol exhibits significant antiviral activity by inhibiting the HSV-2 proliferation process and HSV-2-induced TNF-α increasing levels, decreasing RIP3 and MLKL protein expressions through the intracellular RIP3-mediated programmed cell necrosis pathway. In addition, carvacrol also may exhibit anti-HSV-2 activity by reversing the ubiquitination decrease level caused by HSV-2 infection on the ubiquitin-proteasome system, which provides insights into the molecular mechanism.

Indexed as

AnimalsAntiviral AgentsApoptosisChlorocebus aethiopsCymenesCytokinesEpithelial CellsHerpes SimplexHerpesvirus 1, HumanHerpesvirus 2, HumanProteasome Endopeptidase ComplexReceptor-Interacting Protein Serine-Threonine KinasesSignal TransductionUbiquitinVero CellsVirus ReplicationAntiviral AgentscarvacrolCymenesCytokinesProteasome Endopeptidase ComplexReceptor-Interacting Protein Serine-Threonine KinasesUbiquitinAntiviral activityCarvacrolHerpes simplex virus-2 (HSV-2)Programmed cell necrosisUbiquitin-proteasome

Identifiers

PMID33176697
PMCPMC7661259
OpenAlexW3098963813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.